What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Interview Jul 19, 2024
Expanding the Alimentiv Site Network: An Interview With Peter Westerveld

The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring…

Article Sep 8, 2023
Different Types of Clinical Trial Designs

Clinical trial designs can be classified into several categories, each with its unique characteristics and objectives. This guide provides a broad look at the many…

Article Aug 2, 2023
Samples, Assays, and Analyses: Building a Biomarker Plan for Precision Medicine in Clinical Trials

Designing a biomarker plan for a clinical trial can be challenging due to the plethora of assays and advancing technologies that are now readily available….

Article Aug 2, 2023
Why aren’t more Clinical Trials using Adaptive Designs?

If adaptive designs can bring strong advantages to clinical trials, then why does their adoption remain low?  Clinical trials typically follow a fixed design, where…

Article Jun 30, 2023
What is the Difference between Biostatistics and Statistics?

In the life sciences field, there are two terms that often come up when describing the analysis of data; biostatistics and statistics, which are often…

News Jun 26, 2023
Alimentiv Inc. launches Alimentiv Statistics

London, Ontario, Canada, June 27, 2023, Alimentiv Inc. (“Alimentiv”) today announced the launch of Alimentiv Statistics, a core Alimentiv product line focused on being the…

Article Apr 18, 2023
Pharmacokinetics vs Pharmacodynamics: Understanding their role in Drug Discovery

Pharmacokinetics vs Pharmacodynamics: each play a crucial role in the drug discovery process by providing insight into how drugs work in the body and how…